1. GPCR/G Protein Vitamin D Related/Nuclear Receptor
  2. PTHR Thyroid Hormone Receptor
  3. Teriparatide acetate hydrate

Teriparatide acetate hydrate  (Synonyms: 特立帕肽醋酸盐水合物; Human parathyroid hormone-(1-34) acetate hydrate; hPTH (1-34) acetate hydrate)

目录号: HY-P0059A
Data Sheet 产品使用指南

Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) 是 PTH1 受体的激动剂。Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) 可用于骨质疏松症研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Teriparatide acetate hydrate Chemical Structure

Teriparatide acetate hydrate Chemical Structure

CAS No. : 99294-94-7

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Teriparatide acetate hydrate 的其他形式现货产品:

Customer Review

Other Forms of Teriparatide acetate hydrate:

查看 PTHR 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) is a PTH1 receptor agonist. Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) can be used for osteoporosis research[1].

体内研究
(In Vivo)

Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) (20 μg/kg, i.h.; daily, for 4 weeks; female New Zealand white rabbits) increases the cortical thickness and porosity[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female New Zealand white rabbits[1]
Dosage: 20 μg/kg
Administration: Subcutaneous injection; daily, for 4 weeks
Result: Increased the pore ratio, number, and density as well as the cortical area, thickness, and bone mineral content (BMC), without significant influencing the volumetric bone mineral density (BMD).
Clinical Trial
NCT NumberSponsorConditionStart DatePhase
NCT00543023Eli Lilly and Company
Osteoporosis, Post-Menopausal
June 2003Phase 3
NCT00489918Zosano Pharma Corporation
Osteoporosis
June 2007Phase 2
NCT01656629Johns Hopkins University
Low Bone Density
August 2012Not Applicable
Formula

C181H291N55O51S2.C2H4O2.xH2O

CAS 号
Sequence Shortening

SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF

中文名称

特立帕肽醋酸盐水合物

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Teriparatide acetate hydrate
目录号:
HY-P0059A
需求量:
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》